Self Medication in Odontology (AUDE)

Dental Anxiety Clinical Trial

— AUDE  

Official title:

Self Medication and Pulpal and Periapical Dental Pain

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04949126
• Other study ID #: RNI 2021 COUSSON
• Secondary ID: 2021-A00417-34
• Status: Completed
• Start date: June 15, 2021
• Est. completion date: May 12, 2023

Study information

• Verified date: June 2023
• Source: University Hospital, Clermont-Ferrand
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

To describe and understand the self-medication behaviours of a population of adults coming to the Clermont-Ferrand dentistry department for acute pain of pulpal origin and of a population of adults coming to the specific care unit of the Clermont-Ferrand dentistry department or the Riom hospital for treatment under general anaesthesia.

Description:

Self-medication behaviour will be studied by means of a questionnaire. Questionnaires on insecurity, anxiety about dental care, items related to the ingestion function of the International Classification of Functioning, Disability and Health (ICF), a visual analogue pain assessment scale and the PCS-CF pain dramatisation scale will also be used.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 940
• Est. completion date: May 12, 2023
• Est. primary completion date: May 12, 2023
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Adult patient, male or female, coming to consult in the Clermont-Ferrand or Riom Hospital for acute pain of pulp origin and periapical OR eligible for dental treatment under general anesthesia in a context phobic.
• Understanding and practicing French
• giving informed consent to participate in research.
• Affiliation to a Social Security scheme.

Exclusion Criteria:

• Patients under guardianship.
• Patient's refusal to participate in the study.

Related Conditions & MeSH terms

• Dental Anxiety
• Dental Pain
• Toothache

Intervention

Behavioral:
• questionnaire
questionnaires of precarity, dental anxiety, self medication, pain

Locations

Country	Name	City	State
France	CHU de Clermont-Ferrand	Clermont-Ferrand

Sponsors (1)

Lead Sponsor	Collaborator
University Hospital, Clermont-Ferrand

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	description of the self-medication behaviours	evaluated by patient interrogation	day 0
Secondary	level of anxiety	: evaluated with IDAF 4C (anxiety module between 8-40, phobia module between 5-10 and anxious situations between 10 and 50), the higher the score, the more anxious the patient is	day 0
Secondary	level of insecurity	evaluated by questionnaire (EPICES (the patient is in situation of insecurity if the score is higher than 30))	day 0
Secondary	description of the oral health with the related to the ingestion function of the International Classification of Functioning, Disability and Health (ICF)	each item is evaluated with a Lickert scale	day 0
Secondary	visual analogue pain assessment scale and the PCS-CF pain dramatisation scale	PCS-CF scale is evaluated between 0 and 52, the higher the score, the more patient is over reacting faced with pain	Day 0